Product Information

NAMZARIC 7 MG-10 MG CAPSULE is a brand product labeled by Allergan, Inc., priced at $19.8207 per EA under NDC 00456120730. Its NADAC has been published 479 times since Jun 21, 2017.

FDA first approved this application on Dec 23, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAMZARIC 7 MG-10 MG CAPSULE

memantine hydrochloride and donepezil hydrochloride
$19.8207per EA

Strength

10; 7 mg/1; mg/1

Manufacturer

Allergan, Inc.

NDC

00456120730

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Approval Type

New Drug (NDA)

FDA Application

NDA206439

FDA Approved

12/23/2014

TE Code

AB

On Market Since

7/18/2016

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors
N-methyl-D-aspartate Receptor Antagonist
NMDA Receptor Antagonists

Price Statistics

The NADAC for NAMZARIC 7 MG-10 MG CAPSULE has been published 479 times since Jun 21, 2017, and over the history we have for it it has risen 61.4%. The table below summarizes its recorded NADAC range and movement.

Current price$19.8207 per EA
All-time high$19.8479 (May 14, 2025)
All-time low$12.2830 (Jun 21, 2017)
52-week high$19.8250
52-week low$19.8004
Median price$16.3349
Average price$16.6828
Largest weekly change+9.5% (Jan 10, 2018)
Weeks tracked479
Tracking sinceJun 21, 2017

Price History

1W

-0.0%

1M

-0.0%

3M

+0.1%

6M

+0.0%

1Y

-0.0%

3Y

+10.1%

5Y

+21.3%

All

+61.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the memantine hydrochloride and donepezil hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of NAMZARIC 7 MG-10 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for NAMZARIC 7 MG-10 MG CAPSULE, manufactured by Allergan, Inc., is $19.8207 per EA (NDC 00456120730), effective Aug 19, 2026.

How has the price of NAMZARIC 7 MG-10 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for NAMZARIC 7 MG-10 MG CAPSULE has risen 61.4%. It has been tracked across 479 weekly CMS publications since Jun 21, 2017.

What are the highest and lowest recorded NADAC prices for NAMZARIC 7 MG-10 MG CAPSULE?

Since Jun 21, 2017, the NADAC for NAMZARIC 7 MG-10 MG CAPSULE has ranged from a low of $12.2830 (Jun 21, 2017) to a high of $19.8479 (May 14, 2025), with a median of $16.3349 per EA.

Are there cheaper alternatives to NAMZARIC 7 MG-10 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of NAMZARIC 7 MG-10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NAMZARIC 7 MG-10 MG CAPSULE?

NAMZARIC 7 MG-10 MG CAPSULE (NDC 00456120730) is labeled by Allergan, Inc., and CMS classifies it as a brand product.